Home › Trial NCT00820170
Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
- Trial IDNCT00820170
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorMemorial Sloan Kettering Cancer Center
- Enrollment55
- Start date2009-01
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.